BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17304557)

  • 1. Factors affecting protein refolding yields in a fed-batch and batch-refolding system.
    Mannall GJ; Titchener-Hooker NJ; Dalby PA
    Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical assessment of the impact of mixing on dilution refolding.
    Mannall GJ; Titchener-Hooker NJ; Chase HA; Dalby PA
    Biotechnol Bioeng; 2006 Apr; 93(5):955-63. PubMed ID: 16353172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling and simulation of fed-batch protein refolding process.
    Dong XY; Shi GQ; Li W; Sun Y
    Biotechnol Prog; 2004; 20(4):1213-9. PubMed ID: 15296450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
    Cabrita LD; Bottomley SP
    Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography.
    Chen Y; Leong SS
    J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
    Misawa S; Kumagai I
    Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical refolding of proteins: Do we have freedom to operate?
    Eiberle MK; Jungbauer A
    Biotechnol J; 2010 Jun; 5(6):547-59. PubMed ID: 20518058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone-assisted column refolding of gloshedobin with the use of refolding cocktail.
    Nian R; Tan L; Yoo IK; Choe WS
    J Chromatogr A; 2008 Dec; 1214(1-2):47-58. PubMed ID: 19004452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of an Escherichia coli strain engineered in the substrate uptake system for improved culture performance at high glucose and cell concentrations: an alternative to fed-batch cultures.
    Lara AR; Caspeta L; Gosset G; Bolívar F; Ramírez OT
    Biotechnol Bioeng; 2008 Mar; 99(4):893-901. PubMed ID: 17929322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the design-of-experiments approach for the development of a refolding technology for progenipoietin-1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies.
    Boyle DM; Buckley JJ; Johnson GV; Rathore A; Gustafson ME
    Biotechnol Appl Biochem; 2009 Jul; 54(2):85-92. PubMed ID: 19435462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding strategies for ketosteroid isomerase following insoluble expression in Escherichia coli.
    Hutchinson MH; Chase HA
    Biotechnol Bioeng; 2006 Aug; 94(6):1089-98. PubMed ID: 16572455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant protein folding and misfolding in Escherichia coli.
    Baneyx F; Mujacic M
    Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refolding of proteins from inclusion bodies is favored by a diminished hydrophobic effect at elevated pressures.
    Crisman RL; Randolph TW
    Biotechnol Bioeng; 2009 Feb; 102(2):483-92. PubMed ID: 18781701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel protein refolding method using a zeolite.
    Chiku H; Kawai A; Ishibashi T; Takehara M; Yanai T; Mizukami F; Sakaguchi K
    Anal Biochem; 2006 Jan; 348(2):307-14. PubMed ID: 16316618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli.
    Jin HJ; Dunn MA; Borthakur D; Kim YS
    Protein Expr Purif; 2004 May; 35(1):1-10. PubMed ID: 15039059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of a prediction model in inclusion body refolding].
    Zhang T; Wang JF; Feng YY; Yang Z; Ma L; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2156-60. PubMed ID: 19923054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-column refolding of corticotropin-releasing factor receptor 1 extracellular domain by size exclusion chromatography.
    Ersoy M; Matic S; Schmidt SR
    Biomed Chromatogr; 2009 Oct; 23(10):1121-8. PubMed ID: 19404927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.